doi: 10.1016/j.mayocp.2012.07.007.
The high cost of cancer drugs and what we can do about it
Affiliations
- PMID: 23036669
- PMCID: PMC3538397
- DOI: 10.1016/j.mayocp.2012.07.007
Item in Clipboard
The high cost of cancer drugs and what we can do about it
Mayo Clin Proc.
2012 Oct.
No abstract available
Comment in
-
Integrating value assessment into discussions about the price of cancer drugs.Mayo Clin Proc. 2012 Oct;87(10):932-4. doi: 10.1016/j.mayocp.2012.08.009. Mayo Clin Proc. 2012. PMID: 23036668 Free PMC article. No abstract available.
-
The high cost of cancer drugs and what we can do about it.Mayo Clin Proc. 2013 Mar;88(3):306. doi: 10.1016/j.mayocp.2013.01.003. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489458 No abstract available.
-
In reply.Mayo Clin Proc. 2013 Mar;88(3):306-7. doi: 10.1016/j.mayocp.2013.01.001. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489459 No abstract available.
Similar articles
-
The high cost of cancer drugs and what we can do about it.Mayo Clin Proc. 2013 Mar;88(3):306. doi: 10.1016/j.mayocp.2013.01.003. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489458 No abstract available.
-
Integrating value assessment into discussions about the price of cancer drugs.Mayo Clin Proc. 2012 Oct;87(10):932-4. doi: 10.1016/j.mayocp.2012.08.009. Mayo Clin Proc. 2012. PMID: 23036668 Free PMC article. No abstract available.
-
In reply.Mayo Clin Proc. 2013 Mar;88(3):306-7. doi: 10.1016/j.mayocp.2013.01.001. Epub 2013 Feb 27. Mayo Clin Proc. 2013. PMID: 23489459 No abstract available.
-
American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.J Oncol Pract. 2018 Mar;14(3):187-192. doi: 10.1200/JOP.2017.027359. Epub 2017 Nov 1. J Oncol Pract. 2018. PMID: 29091534 Review. No abstract available.
-
Trends in the Cost of Cancer Care: Beyond Drugs.J Clin Oncol. 2020 Feb 1;38(4):316-322. doi: 10.1200/JCO.19.01963. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804864 Free PMC article. Review. No abstract available.
Cited by
-
Review of Current Policy Strategies to Reduce US Cancer Drug Costs.J Clin Oncol. 2020 Feb 1;38(4):372-379. doi: 10.1200/JCO.19.01628. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804856 Free PMC article. Review. No abstract available.
-
Cost-effectiveness of the Collaborative Care to Preserve Performance in Cancer (COPE) trial tele-rehabilitation interventions for patients with advanced cancers.Cancer Med. 2020 Apr;9(8):2723-2731. doi: 10.1002/cam4.2837. Epub 2020 Feb 23. Cancer Med. 2020. PMID: 32090502 Free PMC article. Clinical Trial.
-
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.BMC Health Serv Res. 2020 May 14;20(1):424. doi: 10.1186/s12913-020-05167-9. BMC Health Serv Res. 2020. PMID: 32410676 Free PMC article.
-
A microfluidic platform for functional testing of cancer drugs on intact tumor slices.Lab Chip. 2020 May 7;20(9):1658-1675. doi: 10.1039/c9lc00811j. Epub 2020 Apr 9. Lab Chip. 2020. PMID: 32270149 Free PMC article.
-
Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives.Med Oncol. 2024 Apr 23;41(5):125. doi: 10.1007/s12032-024-02327-3. Med Oncol. 2024. PMID: 38652207 Review.
References
-
- Robert C., Thomas L., Bondarenko I. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517–2526. - PubMed
-
- Meropol N.J., Schulman K.A. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25(2):180–186. - PubMed
-
- Leveque D. Off-label use of anticancer drugs. Lancet Oncol. 2008;9(11):1102–1107. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
